pharmaphorum Podcast

A new hope in cachexia and an outsider’s view on pharma

In the latest installment of the pharmaphorum podcast, Editor in Chief Jonah Comstock sits down with Russell Potterfield, CEO at Endevica Pharma.
A biotech CEO who comes from the business and investment worlds, Russell now runs Endevica, which is working on a novel therapy for cachexia, a wasting syndrome that accompanies many cancers.

Why is digital health so challenging for big tech?

In this episode of the pharmaphorum podcast, host Jonah Comstock taps XIL Health’s Susan Lang to better understand why big tech’s ventures into healthcare seem to stumble more often than not.

Live from Frontiers Health 2022 - the pharmaphorum podcast

In this special, live edition of the pharmaphorum podcast, recorded at the conclusion of Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock and pharmaphorum Web Editor Nicole Raleigh are joined by author, consultant, and podcast host Tony Estrella and Healthware Labs Managing Director Kristin Milburn to discuss their key takeaways from the show last week in Milan.

Live from Reuters Pharma 2022 - the pharmaphorum podcast

In mid-October, our Web Editor Nicole Raleigh and Deep Dive Editor Eloise McLellan traveled to Nice for the Reuters Pharma event.
This special episode includes a conversation recorded on-site with Nicole, Eloise, Virtual Science AI CEO Thomas Hughes, and VSAI VP of global patient affairs Geraldine Reilly.
And stay tuned for the second half of the episode, where Nicole speaks with Sabine Hutchison, CEO and co-founder of Seuss+, about the Dutch consulting firm’s work with smaller life science companies.

Building agile partner relationships at a vaccine-focused biotech

In this episode of the pharmaphorum, Dr Paul Tunnah chats with Jeff Baxter, CEO of VBI Vaccines and Lee Taurman, executive vice president full service commercial at Syneos Health.
 

Understanding the tumour micro-environment – the pharmaphorum podcast

Dr Marie-Louise Fjällskog, chief medical officer at Faron Pharmaceuticals, joins host Jonah Comstock for the pharmaphorum podcast this week to give us a primer on the tumour micro-environment, what it is, how we understand it, and what it means for the future of cancer care.

How a once-weekly insulin could disrupt diabetes management

In the latest pharmaphorum podcast, Florian Baeres, Corporate Vice President for global medical affairs at Novo Nordisk, joins editor in chief Jonah Comstock to talk about the innovative once-weekly insulin currently in development and how it could change the game for people currently managing their type 2 diabetes with daily injections.

How these parents of a child with a rare disease are making precision medicine work for them

In today’s pharmaphorum podcast, editor in chief Jonah Comstock invites Drs Zachary and Geri Landman to tell their daughter Lucy’s story and the story of their new nonprofit Moonshots for Unicorns, which sets up a framework for parents in their circumstance to directly crowdfund research for rare single-gene disorders – starting with PGAP3.

AI-derived cancer vaccines

Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science officer respectively of Transgene, to discuss cancer vaccines in general and Transgene’s recent work in the space in particular. 

Challenges and opportunities in the off-patent sector

In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Rebecca Guntern, vice president of medicines for Europe at Sandoz.
Rebecca speaks about generics and biosimilars: what they are, why they’re important for medication access and healthcare cost sustainability, and what Sandoz has learned about succeeding in the off-patent world. She also touches on the patient stories behind the headlines and the effect of COVID-19 on the generics market.